1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. The threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis
5. STRUCTURAL HEART DEVICE, BY PRODUCT TYPE
5.1. Introduction
5.2. Heart Valve Device
5.3. Occluders
5.4. PFO Occluders
5.5. ASD Occluders
5.6. VSD Occluders
5.7. LAA Occluders
6. STRUCTURAL HEART DEVICE MARKET, BY PROCEDURE
6.1. Introduction
6.2. Cardiac Catherization /Minimally Invasive
6.3. Open Heart Surgery
7. STRUCTURAL HEART DEVICE MARKET, BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Spain
7.4.5. Others
7.5. The Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Israel
7.5.4. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. South Korea
7.6.4. Taiwan
7.6.5. Thailand
7.6.6. Indonesia
7.6.7. Japan
7.6.8. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrative
8.3. Mergers, Acquisition, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Edwards Lifesciences Corporation
9.2. Medtronic
9.3. Abbott
9.4. Boston Scientific Corporation
9.5. CryoLife, Inc.
9.6. Gyrus Capital
9.7. Micro Interventional Devices Inc.
9.8. OSCOR, Inc.
9.9. Comed B.V.